Arizona’s bioscience industry isn’t just growing. It’s outpacing the nation.
The 2026 edition of The U.S. Bioscience Economy from TEConomy Partners and the Biotechnology Innovation Organization (BIO) gives us a fresh look at how Arizona stacks up. The short version: since 2021, our bioscience workforce has grown 13.4 percent, nearly twice the national rate of 7.0 percent. Here’s what’s driving that momentum.Continue reading
WASHINGTON, DC (October 28, 2026) – Today, the Biotechnology Innovation Organization (BIO) and the Council of State Bioscience Associations (CSBA) released new national and state-level data on the U.S. bioscience industry’s economic impact.
Oct. 28, 2026 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the U.S. commercial launch of the BD® Liverty™ TIPS Stent Graft, advancing portal hypertension care by giving physicians greater flexibility to tailor treatment to each patient’s hemodynamic needs. The next generation transjugular intrahepatic portosystemic shunt (TIPS) system is designed to provide physicians with deployment accuracy and control, and the flexibility to tailor treatment based on individual patient anatomy, disease progression and clinical goals. The product enters the U.S. market with established clinical and physician experience in Europe and is supported by the six-month interim results from the 177 patient, prospective, multi-center ARCH clinical study, the first and only IDE study with small TIPS diameter (6-7 mm) clinical data.Continue reading
WASHINGTON– The U.S. Department of the Treasury (Treasury) today issued a Notice of Proposed Rulemaking (NPRM) to propose updates to the Outbound Investment Security Program (OISP) based on direction from Congress in the Comprehensive Outbound Investment Security (COINS) Act, passed as part of the Fiscal Year 2026 National Defense Authorization Act. The COINS Act codifies the U.S. Government’s approach to regulating certain outbound investments by U.S. persons and builds upon Treasury’s existing OISP.
NIH SBIR funding from the National Heart, Lung, and Blood Institute advances the secure data platform behind a wearable designed to ease the burden of manual vital-signs checks and to support better-informed care whether in the hospital or at home.Continue reading
Precision medicine pioneer to establish new clinical lab in Arizona, bringing predictive testing for renal denervation to marketContinue reading
Each year, AZBio looks back across the legislative session to identify those leaders whose actions and active engagement support the growth of Arizona’s life science and healthcare industry and help to ensure the people of Arizona benefit from its success. Scores are then tallied and the top ten legislative leaders are named the year’s Trailblazers.
The Arizona Bioindustry Association (AZBio) will honor Arizona Legislators on December 10, 2026 for their service to the community and for championing research, education, innovation, the growth of Arizona’s bioscience sector, and for ensuring that Arizona patients benefit from life science innovation.
WASHINGTON, D.C.—OCTOBER 19, 2026—President Donald J. Trump, with the leadership and support of First Lady Melania Trump, today signed an executive order, Advancing Women’s Health to Improve Outcomes in All Phases of Life, which directs the U.S. Department of Health and Human Services (HHS) to establish a new Women’s Health Division within the National Institutes of Health (NIH) to strengthen scientific research, accelerate medical breakthroughs, and improve health outcomes for American women and girls.Continue reading
On August 31, 2026, the U.S. Food and Drug Administration (FDA) and the U.S. Securities and Exchange Commission (SEC) entered a Memorandum of Understanding (MOU) to enhance cooperation in their regulatory and enforcement responsibilities to improve market oversight and compliance.Continue reading